US approves Emergent’s smallpox vaccine for people at high risk of mpox

In a bid to deal with mpox infection, the US Food and Drug Administration (FDA) approved expanded use of Emergent BioSolutions’ EBS.N ACAM2000 smallpox vaccine to include people at high risk for the disease, the company said on Thursday.

Earlier this month, the World Health…